Northern Trust Corp Has $17.75 Million Stake in Alignment Healthcare, Inc. $ALHC

Key Points

• Northern Trust Corp increased its stake in Alignment Healthcare, Inc. by 4.9% in Q1, owning over 953,000 shares valued at approximately $17.75 million.
• Multiple equity analysts have upgraded their ratings for Alignment Healthcare, with a consensus price target now set at $18.83 after recent upgrades.
• Alignment Healthcare reported a 49% increase in quarterly revenue year-over-year, achieving $1.02 billion, and beat earnings per share estimates significantly.

Northern Trust Corp lifted its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 4.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 953,516 shares of the company's stock after buying an additional 44,552 shares during the quarter. Northern Trust Corp owned about 0.48% of Alignment Healthcare worth $17,754,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of ALHC. Tower Research Capital LLC TRC grew its holdings in Alignment Healthcare by 146.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock worth $119,000 after acquiring an additional 6,286 shares during the period. The Manufacturers Life Insurance Company boosted its position in shares of Alignment Healthcare by 63.3% during the 4th quarter. The Manufacturers Life Insurance Company now owns 210,544 shares of the company's stock valued at $2,369,000 after purchasing an additional 81,611 shares in the last quarter. Algert Global LLC boosted its position in shares of Alignment Healthcare by 115.1% during the 4th quarter. Algert Global LLC now owns 174,012 shares of the company's stock valued at $1,958,000 after purchasing an additional 93,109 shares in the last quarter. Ameriprise Financial Inc. acquired a new stake in Alignment Healthcare during the fourth quarter worth approximately $14,155,000. Finally, BNP Paribas Financial Markets bought a new stake in Alignment Healthcare in the fourth quarter worth approximately $234,000. Institutional investors own 86.19% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on ALHC shares. KeyCorp upgraded Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target on the stock in a report on Monday, August 25th. Zacks Research upgraded shares of Alignment Healthcare to a "hold" rating in a research report on Friday, August 8th. Wall Street Zen cut shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. Barclays raised shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and lifted their price target for the company from $9.00 to $13.00 in a research note on Thursday, July 31st. Finally, Stephens raised shares of Alignment Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $18.83.

Alignment Healthcare Stock Performance

Shares of ALHC opened at $16.64 on Wednesday. The firm has a market capitalization of $3.30 billion, a P/E ratio of -59.43 and a beta of 1.17. Alignment Healthcare, Inc. has a 52 week low of $8.65 and a 52 week high of $21.06. The stock has a 50 day moving average price of $14.03 and a two-hundred day moving average price of $15.38. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.14. The company had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.Alignment Healthcare's quarterly revenue was up 49.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Insider Transactions at Alignment Healthcare

In other news, insider Christopher J. Joyce sold 15,491 shares of the stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $16.01, for a total value of $248,010.91. Following the completion of the sale, the insider owned 374,531 shares in the company, valued at $5,996,241.31. This represents a 3.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Andreas P. Wagner sold 12,032 shares of the business's stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $16.47, for a total transaction of $198,167.04. Following the transaction, the insider owned 192,043 shares in the company, valued at approximately $3,162,948.21. This trade represents a 5.90% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 636,185 shares of company stock worth $9,235,468. 6.60% of the stock is owned by insiders.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Want to see what other hedge funds are holding ALHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.